Disease: Glycogen storage disease type 6- due to phosphorylation
- A highly prevalent equine glycogen storage disease is explained by constitutive activation of a mutant glycogen synthase
- Aberrant glucose metabolism underlies impaired macrophage differentiation in glycogen storage disease type Ib
- Aberrant proliferation and differentiation of glycogen storage disease type Ib mesenchymal stem cells
- Activated mTOR signaling pathway in myofibers with inherited metabolic defect might be an evidence for mTOR inhibition therapies
- Activation of tumor-promoting pathways implicated in hepatocellular adenoma/carcinoma, a long-term complication of glycogen storage disease type Ia
- Asp263 missense variants perturb the active site of human phosphoglucomutase 1
- Clinical and Molecular Variability in Patients with PHKA2 Variants and Liver Phosphorylase b Kinase Deficiency
- Glucose-6-phosphate transporter mediates macrophage proliferation and functions by regulating glycolysis and mitochondrial respiration
- Hepatic ChREBP orchestrates intrahepatic carbohydrate metabolism to limit hepatic glucose 6-phosphate and glycogen accumulation in a mouse model for acute Glycogen Storage Disease type Ib
- Hepatic ChREBP orchestrates intrahepatic carbohydrate metabolism to limit hepatic glucose 6-phosphate and glycogen accumulation in a mouse model for acute Glycogen Storage Disease type Ib (6675 words)
- Hepatic mitochondrial dysfunction is a feature of Glycogen Storage Disease Type Ia (GSDIa)
- Hepatocytes contribute to residual glucose production in a mouse model for glycogen storage disease type Ia
- IRS-1/PI3K/Akt pathway and miRNAs are involved in whole grain highland barley (<em>Hordeum vulgare</em> L.) ameliorating hyperglycemia of db/db mice
- Liver Phosphoenolpyruvate Carboxykinase-1 Downregulation via siRNA-Functionalized Graphene Oxide Nanosheets Restores Glucose Homeostasis in a Type 2 Diabetes Mellitus <em>In Vivo</em> Model
- Liver Phosphoenolpyruvate Carboxykinase-1 Downregulation via siRNA-Functionalized Graphene Oxide Nanosheets Restores Glucose Homeostasis in a Type 2 Diabetes Mellitus In Vivo Model
- Sirtuin signaling controls mitochondrial function in glycogen storage disease type Ia
- SLGT2 Inhibitor Rescues Myelopoiesis in G6PC3 Deficiency
- The role of kidney in the inter-organ coordination of endogenous glucose production during fasting
- The SGLT2-inhibitor dapagliflozin improves neutropenia and neutrophil dysfunction in a mouse model of the inherited metabolic disorder GSDIb